145 related articles for article (PubMed ID: 37333151)
1. CNP blocks mitochondrial depolarization and inhibits SARS-CoV-2 replication
Logue J; Melville VM; Ardanuy J; Frieman MB
bioRxiv; 2023 Dec; ():. PubMed ID: 37333151
[TBL] [Abstract][Full Text] [Related]
2. CNP blocks mitochondrial depolarization and inhibits SARS-CoV-2 replication in vitro and in vivo.
Logue J; Melville VM; Ardanuy J; Frieman MB
PLoS Pathog; 2023 Dec; 19(12):e1011870. PubMed ID: 38117830
[TBL] [Abstract][Full Text] [Related]
3. Amuvatinib Blocks SARS-CoV-2 Infection at the Entry Step of the Viral Life Cycle.
Huynh TTX; Pham TX; Lee GH; Lee JB; Lee SG; Tark D; Lim YS; Hwang SB
Microbiol Spectr; 2023 Jun; 11(3):e0510522. PubMed ID: 36995225
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial 2', 3'-cyclic nucleotide 3'-phosphodiesterase (CNP) interacts with mPTP modulators and functional complexes (I-V) coupled with release of apoptotic factors.
Baburina Y; Azarashvili T; Grachev D; Krestinina O; Galvita A; Stricker R; Reiser G
Neurochem Int; 2015 Nov; 90():46-55. PubMed ID: 26188334
[TBL] [Abstract][Full Text] [Related]
5. The FDA-Approved Drug Cobicistat Synergizes with Remdesivir To Inhibit SARS-CoV-2 Replication
Shytaj IL; Fares M; Gallucci L; Lucic B; Tolba MM; Zimmermann L; Adler JM; Xing N; Bushe J; Gruber AD; Ambiel I; Taha Ayoub A; Cortese M; Neufeldt CJ; Stolp B; Sobhy MH; Fathy M; Zhao M; Laketa V; Diaz RS; Sutton RE; Chlanda P; Boulant S; Bartenschlager R; Stanifer ML; Fackler OT; Trimpert J; Savarino A; Lusic M
mBio; 2022 Apr; 13(2):e0370521. PubMed ID: 35229634
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of HIV-1 particle assembly by 2',3'-cyclic-nucleotide 3'-phosphodiesterase.
Wilson SJ; Schoggins JW; Zang T; Kutluay SB; Jouvenet N; Alim MA; Bitzegeio J; Rice CM; Bieniasz PD
Cell Host Microbe; 2012 Oct; 12(4):585-97. PubMed ID: 23084924
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of green tea catechin, (-)-epigallocatechin-3-
Dinda B; Dinda S; Dinda M
Phytomed Plus; 2023 Feb; 3(1):100402. PubMed ID: 36597465
[TBL] [Abstract][Full Text] [Related]
8. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
[TBL] [Abstract][Full Text] [Related]
9. In aging, the vulnerability of rat brain mitochondria is enhanced due to reduced level of 2',3'-cyclic nucleotide-3'-phosphodiesterase (CNP) and subsequently increased permeability transition in brain mitochondria in old animals.
Krestinina O; Azarashvili T; Baburina Y; Galvita A; Grachev D; Stricker R; Reiser G
Neurochem Int; 2015 Jan; 80():41-50. PubMed ID: 25277077
[TBL] [Abstract][Full Text] [Related]
10. Severe Acute Respiratory Syndrome Coronavirus ORF7a Inhibits Bone Marrow Stromal Antigen 2 Virion Tethering through a Novel Mechanism of Glycosylation Interference.
Taylor JK; Coleman CM; Postel S; Sisk JM; Bernbaum JG; Venkataraman T; Sundberg EJ; Frieman MB
J Virol; 2015 Dec; 89(23):11820-33. PubMed ID: 26378163
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic targeting of the ACE2 and NRP1 viral receptors limits SARS-CoV-2 infectivity.
Saiz ML; DeDiego ML; López-García D; Corte-Iglesias V; Baragaño Raneros A; Astola I; Asensi V; López-Larrea C; Suarez-Alvarez B
Clin Epigenetics; 2021 Oct; 13(1):187. PubMed ID: 34635175
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of SARS-CoV-2 polymerase by nucleotide analogs from a single-molecule perspective.
Seifert M; Bera SC; van Nies P; Kirchdoerfer RN; Shannon A; Le TT; Meng X; Xia H; Wood JM; Harris LD; Papini FS; Arnold JJ; Almo S; Grove TL; Shi PY; Xiang Y; Canard B; Depken M; Cameron CE; Dulin D
Elife; 2021 Oct; 10():. PubMed ID: 34617885
[TBL] [Abstract][Full Text] [Related]
13. Honokiol Inhibits SARS-CoV-2 Replication in Cell Culture at a Post-Entry Step.
Salgado-Benvindo C; Leijs AA; Thaler M; Tas A; Arbiser JL; Snijder EJ; van Hemert MJ
Microbiol Spectr; 2023 Jun; 11(3):e0327322. PubMed ID: 37212560
[TBL] [Abstract][Full Text] [Related]
14. Identification of potential inhibitors against SARS-CoV-2 by targeting proteins responsible for envelope formation and virion assembly using docking based virtual screening, and pharmacokinetics approaches.
Bhowmik D; Nandi R; Jagadeesan R; Kumar N; Prakash A; Kumar D
Infect Genet Evol; 2020 Oct; 84():104451. PubMed ID: 32640381
[TBL] [Abstract][Full Text] [Related]
15. The rocaglate CR-31-B (-) inhibits SARS-CoV-2 replication at non-cytotoxic, low nanomolar concentrations in vitro and ex vivo.
Müller C; Obermann W; Karl N; Wendel HG; Taroncher-Oldenburg G; Pleschka S; Hartmann RK; Grünweller A; Ziebuhr J
Antiviral Res; 2021 Feb; 186():105012. PubMed ID: 33422611
[TBL] [Abstract][Full Text] [Related]
16. Generation and Characterization of recombinant SARS-CoV-2 expressing reporter genes.
Chiem K; Morales Vasquez D; Park JG; Platt RN; Anderson T; Walter MR; Kobie JJ; Ye C; Martinez-Sobrido L
J Virol; 2021 Mar; 95(7):. PubMed ID: 33431557
[TBL] [Abstract][Full Text] [Related]
17. Disulfiram blocked cell entry of SARS-CoV-2 via inhibiting the interaction of spike protein and ACE2.
Chen HF; Hsueh PR; Liu YY; Chen Y; Chang SY; Wang WJ; Wu CS; Tsai YM; Liu YS; Su WC; Chou YC; Hung MC
Am J Cancer Res; 2022; 12(7):3333-3346. PubMed ID: 35968340
[TBL] [Abstract][Full Text] [Related]
18. Brequinar and dipyridamole in combination exhibits synergistic antiviral activity against SARS-CoV-2 in vitro: Rationale for a host-acting antiviral treatment strategy for COVID-19.
Demarest JF; Kienle M; Boytz R; Ayres M; Kim EJ; Patten JJ; Chung D; Gandhi V; Davey RA; Sykes DB; Shohdy N; Pottage JC; Kumar VS
Antiviral Res; 2022 Oct; 206():105403. PubMed ID: 36041646
[TBL] [Abstract][Full Text] [Related]
19. A trifunctional peptide broadly inhibits SARS-CoV-2 Delta and Omicron variants in hamsters.
Zhao H; To KK; Lam H; Zhang C; Peng Z; Meng X; Wang X; Zhang AJ; Yan B; Cai J; Yeung ML; Chan JF; Yuen KY
Cell Discov; 2022 Jun; 8(1):62. PubMed ID: 35768416
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 Nucleocapsid Protein Is a Potential Therapeutic Target for Anticoronavirus Drug Discovery.
Royster A; Ren S; Ma Y; Pintado M; Kahng E; Rowan S; Mir S; Mir M
Microbiol Spectr; 2023 Jun; 11(3):e0118623. PubMed ID: 37199631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
